Thomson Reuters to divest FindLaw to Internet Brands in strategic reconfiguration

Thomson Reuters to divest FindLaw to Internet Brands in strategic reconfiguration

Thomson Reuters (TSX/NYSE: TRI), a prominent global content and technology enterprise, has announced the execution of a definitive agreement to divest its FindLaw business to Internet Brands, an integrated online media and software services company specializing in high-value vertical markets, particularly in the Health and Legal sectors. This transaction marks a significant shift in Thomson […]

Kite Pharma gets Yescarta approval in Japan for large B-cell lymphoma

Kite Pharma gets Yescarta approval in Japan for large B-cell lymphoma

Kite Pharma, a subsidiary of Gilead Sciences, and Daiichi Sankyo have received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for their Yescarta (axicabtagene ciloleucel) for initial treatment of relapsed/refractory large B-cell lymphoma (LBCL). Yescarta, a chimeric antigen receptor (CAR) T-cell therapy, is used only in patients who have not received a […]

Unilever to acquire US-based electrolyte drink manufacturer Liquid I.V.

Unilever to acquire US-based electrolyte drink manufacturer Liquid I.V.

Unilever has signed a deal to acquire Liquid I.V, a US-based health-science nutrition and wellness company, for an undisclosed price. Based in El Segundo, California, Liquid I.V. was established by entrepreneur Brandin Cohen in 2012. Liquid I.V.’s electrolyte drink mixes leverage Cellular Transport Technology (CTT) which is said to boost the quick absorption of water […]